The Oligonucleotide Synthesis Market is on a trajectory to reach an impressive valuation of USD 58.89 billion by 2035, representing a robust compound annual growth rate (CAGR) of 11.32%. This growth trajectory underscores the increasing demand for oligonucleotides across various applications, particularly in molecular diagnostics and therapeutics. The market size stood at USD 12.38 billion in...